{"nct_id":"NCT00605280","title":"A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2005-09","start_date_type":null,"primary_completion_date":"2009-11","primary_completion_date_type":"ACTUAL","completion_date":"2011-07","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["PFE"]}